Company Filing History:
Years Active: 2022-2024
Title: Fuxiang Lin: Innovator in Pharmaceutical Delivery Systems
Introduction
Fuxiang Lin is a notable inventor based in Xiamen, China, recognized for his contributions to pharmaceutical delivery systems. He holds three patents that focus on innovative methods for drug delivery, enhancing the bioavailability and effectiveness of medications.
Latest Patents
One of Lin's latest patents is the "Tadalafil oral transmucosal film." This invention provides an oral transmucosal film designed to deliver tadalafil through the buccal or sublingual mucosa. The film features a single-layer structure containing amorphous tadalafil, solubilizers, penetration enhancers, and adhesives, which collectively improve the absorption rate compared to traditional oral tablets. The formulation comprises 5%-60% by weight of amorphous tadalafil, 25-96% by weight of a film-forming material, 1-20% by weight of a solubilizer, 0.5-10% by weight of a penetration enhancer, and 1-15% by weight of an adhesive.
Another significant patent is the "Process for preparing aripiprazole oral soluble film." This invention focuses on an aripiprazole oral soluble film that includes 10-60% w/w of crystalline aripiprazole and 30-95% w/w of film-forming materials. The preparation method ensures that 90% of the aripiprazole particles are uniformly blended in the film, resulting in excellent bioavailability, uniformity, stability, and palatability.
Career Highlights
Fuxiang Lin is currently associated with Xiamen LP Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceutical formulations. His work has significantly impacted the development of more effective drug delivery systems.
Collaborations
Lin collaborates with talented individuals such as Rongbin Ling and Lingyu Cai, contributing to the advancement of pharmaceutical technologies.
Conclusion
Fuxiang Lin's innovative work in drug delivery systems exemplifies the importance of advancements in pharmaceuticals. His patents reflect a commitment to improving patient outcomes through enhanced medication delivery methods.